Sibrandes Poppema

Sibrandes Poppema's AcademicInfluence.com Rankings

Sibrandes Poppema

Philosophy

#7525

World Rank

#10749

Historical Rank

Logic

#4578

World Rank

#5888

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Sibrandes Poppema's Degrees

Bachelors Biology University of Amsterdam
Masters Biotechnology University of Amsterdam
PhD Molecular Biology University of Groningen

Similar Degrees You Can Earn

Best Online Bachelor's in Biology 2026

Why Is Sibrandes Poppema Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Sibrandes Poppema's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Increasing the efficacy of CD20 antibody therapy through the engineering of a new type II anti-CD20 antibody with enhanced direct and immune effector cell-mediated B-cell cytotoxicity. (2010) (811)
BIC and miR‐155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas (2005) (716)
Deletion of a DNA sequence at the chromosomal region 3p21 in all major types of lung cancer (1987) (416)
Distribution of T cell subsets in human lymph nodes (1981) (399)
High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma. (1999) (385)
Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease. (1999) (342)
High expression of B‐cell receptor inducible gene BIC in all subtypes of Hodgkin lymphoma (2002) (269)
Location of T cell and major histocompatibility complex antigens in the human thymus (1980) (259)
Immaturity of the human splenic marginal zone in infancy. Possible contribution to the deficient infant immune response. (1989) (259)
European Task Force on Lymphoma project on lymphocyte predominance Hodgkin disease: histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes. (2000) (254)
Monoclonal antibodies (MT1, MT2, MB1, MB2, MB3) reactive with leukocyte subsets in paraffin-embedded tissue sections. (1987) (237)
Primary breast lymphoma: An immunohistologic study of 20 new cases (1990) (205)
Lack of BIC and microRNA miR‐155 expression in primary cases of Burkitt lymphoma (2006) (185)
Chemokines, cytokines and their receptors in Hodgkin's lymphoma cell lines and tissues. (2002) (168)
Prevention and reversal of renal allograft rejection by antibody against CD45RB (1996) (168)
Workshop report on Hodgkin's disease and related diseases ('grey zone' lymphoma). (1998) (166)
Association with HLA class I in Epstein-Barr-virus-positive and with HLA class III in Epstein-Barr-virus-negative Hodgkin's lymphoma (2005) (162)
Regulation of pri-microRNA BIC transcription and processing in Burkitt lymphoma (2007) (161)
Characterization of three new variant type cell lines derived from small cell carcinoma of the lung. (1985) (161)
Nodular lymphocyte predominance type of Hodgkin's disease is a germinal center lymphoma. (1986) (159)
CELLULAR AND HUMORAL IMMUNE-REACTIONS IN CHRONIC ACTIVE LIVER-DISEASE .1. LYMPHOCYTE SUBSETS IN LIVER BIOPSIES OF PATIENTS WITH UNTREATED IDIOPATHIC AUTOIMMUNE HEPATITIS, CHRONIC ACTIVE HEPATITIS-B AND PRIMARY BILIARY-CIRRHOSIS (1982) (155)
Hodgkin lymphoma cell lines are characterized by a specific miRNA expression profile. (2009) (152)
Hodgkin's disease: a tumor with disturbed immunological pathways. (1997) (142)
HLA-A*02 is associated with a reduced risk and HLA-A*01 with an increased risk of developing EBV+ Hodgkin lymphoma. (2007) (141)
In situ immunologic characterization of cellular constituents in lymph nodes and spleens involved by Hodgkin's disease. (1982) (139)
The nature of the lymphocytes surrounding Reed-Sternberg cells in nodular lymphocyte predominance and in other types of Hodgkin's disease. (1989) (139)
Follicular lymphoma grade 3B includes 3 cytogenetically defined subgroups with primary t(14;18), 3q27, or other translocations: t(14;18) and 3q27 are mutually exclusive. (2003) (138)
Ectopic Expression of Human and Feline CD9 in a Human B Cell Line Confers β1 Integrin-dependent Motility on Fibronectin and Laminin Substrates and Enhanced Tyrosine Phosphorylation (*) (1995) (137)
Primary Non‐Hodgkin's lymphoma of the mediastinum (1982) (132)
Proteomics analysis of Hodgkin lymphoma: identification of new players involved in the cross-talk between HRS cells and infiltrating lymphocytes. (2007) (131)
HLA class II expression by Hodgkin Reed-Sternberg cells is an independent prognostic factor in classical Hodgkin's lymphoma. (2007) (129)
Serum chemokine levels in Hodgkin lymphoma patients: highly increased levels of CCL17 and CCL22 (2008) (128)
Active immunization of human ovarian cancer patients against a common carcinoma (Thomsen-Friedenreich) determinant using a synthetic carbohydrate antigen. (1992) (123)
Clinical characterization of non-small-cell lung cancer tumors showing neuroendocrine differentiation features. (1989) (122)
A high throughput experimental approach to identify miRNA targets in human cells (2009) (122)
Clinical significance of bcl-2-MBR gene rearrangement and protein expression in diffuse large-cell non-Hodgkin's lymphoma: an analysis of 83 cases. (1994) (120)
Clonal immunoglobulin gene rearrangements in tissues involved by Hodgkin's disease. (1987) (118)
Immunobiology and pathophysiology of Hodgkin lymphomas. (2005) (113)
Diagnostic application of two-color flow cytometry in 161 cases of hairy cell leukemia. (1993) (109)
Interaction between host T cells and Reed-Sternberg cells in Hodgkin lymphomas. (2000) (108)
The role of microRNAs in normal hematopoiesis and hematopoietic malignancies (2006) (106)
miRNA profiling of B-cell subsets: specific miRNA profile for germinal center B cells with variation between centroblasts and centrocytes (2009) (105)
Antibody-mediated targeting of CD45 isoforms: a novel immunotherapeutic strategy. (1998) (102)
Strongly enhanced IL-10 production using stable galectin-1 homodimers. (2007) (101)
Expression and function of a receptor for hyaluronan-mediated motility on normal and malignant B lymphocytes. (1993) (99)
Workshop on the relationship between nodular lymphocyte predominant Hodgkin's lymphoma and T cell/histiocyte-rich B cell lymphoma. (2002) (98)
Latent Epstein-Barr virus infection of tumor cells in classical Hodgkin's lymphoma predicts adverse outcome in older adult patients. (2009) (98)
Dimeric galectin‐1 induces IL‐10 production in T‐lymphocytes: an important tool in the regulation of the immune response (2004) (96)
Pre-immunotherapy serum CA27.29 (MUC-1) mucin level and CD69+ lymphocytes correlate with effects of Theratope® sialyl-Tn-KLH cancer vaccine in active specific immunotherapy (1996) (96)
Clonal relation in a case of CLL, ALCL, and Hodgkin composite lymphoma. (2002) (95)
Monoclonal antibodies reactive with hairy cell leukemia. (1989) (91)
Neuroendocrine differentiation antigen on human lung carcinoma and Kulchitski cells. (1985) (91)
Characterization of three small cell lung cancer cell lines established from one patient during longitudinal follow-up. (1988) (91)
Fetal and neonatal development of human spleen: an immunohistological study. (1987) (90)
The diversity of the immunohistological staining pattern of Sternberg-Reed cells. (1980) (90)
Lymphocyte compartments in human spleen. An immunohistologic study in normal spleens and uninvolved spleens in Hodgkin's disease. (1985) (89)
Human marginal zone b cells are not an activated b cell subset: strong expression of cd21 as a putative mediator for rapid b cell activation (1989) (88)
Morphologic, immunologic, enzymehistochemical and chromosomal analysis of a cell line derived from Hodgkin's disease. Evidence for a B‐cell origin of sternberg‐reed cells (1985) (87)
B lymphocyte differentiation in the rat: production and characterization of monoclonal antibodies to B lineage‐associated antigens (1987) (86)
Insitu analysis of the mononuclear cell infiltrate in primary malignant-melanoma of the skin (1983) (85)
Development of Lymphoma in Autoimmune Lymphoproliferative Syndrome (ALPS) and its Relationship to Fas Gene Mutations (2004) (84)
Transition in CD45 isoform expression during differentiation of normal and abnormal B cells. (1989) (81)
EXPRESSION OF MAJOR HISTOCOMPATIBILITY COMPLEX ANTIGENS AND REPLACEMENT OF DONOR CELLS BY RECIPIENT ONES IN HUMAN LIVER GRAFTS (1987) (79)
Expression of anti‐OV6 antibody and anti‐N‐CAM antibody along the biliary line of normal and diseased human livers (2001) (77)
Common and differential chemokine expression patterns in rs cells of NLP, EBV positive and negative classical hodgkin lymphomas (2002) (77)
Diagnostic application of two-color flow cytometry in 161 cases of hairy cell leukemia (1993) (77)
The significance of intracytoplasmic proteins in Reed‐Sternberg cells (1978) (74)
HLA-G protein expression as a potential immune escape mechanism in classical Hodgkin's lymphoma. (2008) (73)
TARC, a CC Chemokine, Is Frequently Expressed in Classic Hodgkin's Lymphoma But Not in NLP Hodgkin's Lymphoma, T-Cell-Rich B-Cell Lymphoma, and Most Cases of Anaplastic Large Cell Lymphoma (2001) (72)
Expression of the T-cell transcription factors, GATA-3 and T-bet, in the neoplastic cells of Hodgkin lymphomas. (2005) (71)
Molecular, cytogenetic, and immunophenotypic characterization of follicular lymphoma grade 3B; a separate entity or part of the spectrum of diffuse large B-cell lymphoma or follicular lymphoma? (2006) (71)
CD45 isoform expression on human haemopoietic cells at different stages of development (1994) (70)
The CD4+CD26− T-cell population in classical Hodgkin's lymphoma displays a distinctive regulatory T-cell profile (2008) (70)
Mitoxantrone resistance in a small cell lung cancer cell line is associated with ABCA2 upregulation (2004) (70)
HML-1 antigen on mucosa-associated T cells, activated cells, and hairy leukemic cells is a new integrin containing the beta 7 subunit. (1991) (70)
Lymphocyte-predominance Hodgkin's disease. (1992) (69)
Lymphadenopathy morphologically consistent with Hodgkin's disease associated with Epstein-Barr virus infection. (1985) (67)
Lack of BIC and microRNA miR-155 expression in primary cases of Burkitt lymphoma. (2005) (67)
TP53 gene mutations in Hodgkin lymphoma are infrequent and not associated with absence of Epstein‐Barr virus (2001) (66)
Chromosomal abnormalities in patients with Hodgkin's disease: evidence for frequent involvement of the 14q chromosomal region but infrequent bcl-2 gene rearrangement in Reed-Sternberg cells. (1992) (65)
Novel 3rd Generation Humanized Type II CD20 Antibody with Glycoengineered Fc and Modified Elbow Hinge for Enhanced ADCC and Superior Apoptosis Induction. (2006) (65)
Low frequency of FAS mutations in Reed-Sternberg cells of Hodgkin's lymphoma. (2002) (64)
Absence of HLA class I expression by Reed-Sternberg cells. (1994) (62)
Immunocytology of body cavity fluids. MOC-31, a monoclonal antibody discriminating between mesothelial and epithelial cells. (1994) (62)
HLA Associations in Classical Hodgkin Lymphoma: EBV Status Matters (2012) (60)
Continuous administration of Il-13 to mice induces extramedullary hemopoiesis and monocytosis. (1996) (57)
Immune reactions in classical Hodgkin's lymphoma. (1999) (57)
Reactivity of presumed anti-natural killer cell antibody Leu 7 with intrafollicular T lymphocytes. (1983) (55)
Cellular and humoral immune reactions in chronic active liver disease. II. Lymphocyte subsets and viral antigens in liver biopsies of patients with acute and chronic hepatitis B. (1984) (51)
Cellular and humoral immune reactions in chronic active liver disease. I. Lymphocyte subsets in liver biopsies of patients with untreated idiopathic autoimmune hepatitis, chronic active hepatitis B and primary biliary cirrhosis. (1982) (51)
CD45 (leucocyte common antigen) expression in T and B lymphocyte subsets. (1996) (51)
Contamination of Hodgkin's disease cell cultures (1981) (48)
Serial analysis of gene expression: rapid RT-PCR analysis of unknown SAGE tags. (1999) (48)
A pathologic study of Hodgkin's disease in Korea and its association with the Epstein‐Barr virus infection (1996) (47)
Genetic susceptibility to Hodgkin's lymphoma associated with the human leukocyte antigen region (2005) (45)
Active specific immunotherapy against adenocarcinomas. (1994) (45)
CD69+ and HLA‐DR+ activation antigens on peripheral blood lymphocyte populations in metastatic breast and ovarian cancer patients: Correlations with survival following active specific immunotherapy (1995) (45)
High expression of calcium‐binding proteins, S100A10, S100A11 and CALM2 in anaplastic large cell lymphoma (2005) (44)
The angiogenic makeup of human hepatocellular carcinoma does not favor vascular endothelial growth factor/angiopoietin‐driven sprouting neovascularization (2008) (43)
Expression of Bcl‐2 family members and presence of Epstein–Barr virus in the regulation of cell growth and death in classical Hodgkin's lymphoma (2004) (42)
The Human Leukocyte Antigen Class I Region Is Associated with EBV-Positive Hodgkin's Lymphoma: HLA-A and HLA Complex Group 9 Are Putative Candidate Genes (2006) (42)
Defined in situ enumeration of T6 and HLA-DR expressing epidermal Langerhans cells: morphologic and methodologic aspects. (1986) (41)
Cytokine gene expression profile distinguishes CD4+/CD57+ T cells of the nodular lymphocyte predominance type of Hodgkin's lymphoma from their tonsillar counterparts (2006) (41)
Expression of class II major histocompatibility complex antigens on alveolar epithelium in interstitial lung disease: relevance to pathogenesis of idiopathic pulmonary fibrosis. (1987) (40)
The localization of Hodgkin's disease in lymph nodes. A study with immunohistological, enzyme histochemical and rosetting techniques on frozen sections (1979) (39)
Detection of small cell lung cancer metastases in bone marrow aspirates using monoclonal antibody directed against neuroendocrine differentiation antigen. (1988) (39)
Germline FAS gene mutation in a case of ALPS and NLP Hodgkin lymphoma. (2002) (38)
In situ analysis of the mononuclear cell infiltrate in primary malignant melanoma of the skin. (1983) (38)
Morphologic, immunologic, enzymehistochemical and chromosomal analysis of a cell line derived from Hodgkin's disease (1985) (38)
THE SIGNIFICANCE OF PARENCHYMAL CHANGES OF ACUTE CELLULAR REJECTION IN PREDICTING CHRONIC LIVER GRAFT REJECTION (2002) (38)
Immunoperoxidase staining on frozen tissue sections as a first screening assay in the preparation of monoclonal antibodies directed against small cell carcinoma of the lung. (1984) (38)
Epidemiology of Classical Hodgkin Lymphoma and Its Association with Epstein Barr Virus in Northern China (2011) (38)
MiR‐17/106b seed family regulates p21 in Hodgkin's lymphoma (2011) (38)
The Use of Monoclonal Antibodies for the Pathological Diagnosis of Lung Cancer (1986) (36)
LYMPHOCYTE-T SUB-POPULATIONS IN MULTIPLE-SCLEROSIS LESIONS (1982) (36)
Analysis of chromosomal copy number changes and oncoprotein expression in primary central nervous system lymphomas: frequent loss of chromosome arm 6q (2003) (36)
Demonstration of immunoglobulin in malignant lymphomas. Use of an immunoperoxidase technic on frozen sections. (1982) (36)
Splenic Marginal Zone Lymphomas Presenting with Splenomegaly and Typical Immunophenotype Are Characterized by Allelic Loss in 7q31–32 (2003) (35)
Gene expression analysis of dendritic/Langerhans cells and Langerhans cell histiocytosis (2006) (35)
Infantile histiocytosis X (letterer‐siwe disease). Investigations with enzymehistochemical and sheep‐erythrocyte rosetting techniques (1978) (34)
Global correlation of genome and transcriptome changes in classical Hodgkin lymphoma (2007) (34)
The role of CD30, CD40 and CD95 in the regulation of proliferation and apoptosis in classical Hodgkin's lymphoma (2003) (34)
B-ly-7, a monoclonal antibody reactive with hairy cell leukemia, also defines an activation antigen on normal CD8+ T cells. (1990) (34)
Development of multi-epitope peptide-based vaccines against SARS-CoV-2 (2020) (33)
CHRONIC REJECTION IN LIVER-TRANSPLANTS - A HISTOPATHOLOGIC ANALYSIS OF FAILED GRAFTS AND ANTECEDENT SERIAL BIOPSIES (1986) (33)
Immunophenotypes of malignant lymphoma centroblastic-centrocytic and malignant lymphoma centrocytic: an immunohistologic study indicating a derivation from different stages of B cell differentiation. (1988) (33)
BCL6 alternative translocation breakpoint cluster region associated with follicular lymphoma grade 3B (2005) (32)
Identification of chromosomal copy number changes associated with transformation of follicular lymphoma to diffuse large B-cell lymphoma. (2003) (32)
Monoclonal antibody OPD4 is reactive with CD45RO, but differs from UCHL1 by the absence of monocyte reactivity. (1991) (32)
Heterogeneous expression of proto‐oncogenes in Hodgkin's disease derived cell lines (1990) (32)
Intracranial malignant lymphomas (1978) (32)
BCL6 alternative breakpoint region break and homozygous deletion of 17q24 in the nodular lymphocyte predominance type of Hodgkin's lymphoma-derived cell line DEV. (2006) (31)
Development and characterization of three recombinant single chain antibody fragments (scFvs) directed against the CD19 antigen. (1995) (30)
HLA-A*02:07 Is a Protective Allele for EBV Negative and a Susceptibility Allele for EBV Positive Classical Hodgkin Lymphoma in China (2012) (30)
Expression of the c-Met oncogene by tumor cells predicts a favorable outcome in classical Hodgkin’s lymphoma (2012) (29)
Cryopreservation of newly formed hybridomas. (1983) (29)
Localization of cytosolic aldehyde dehydrogenase in the developing chick retina: In situ hybridization and immunohistochemical analyses (1996) (29)
Expression of retinoblastoma protein and P16 proteins in classic Hodgkin lymphoma: relationship with expression of p53 and presence of Epstein-Barr virus in the regulation of cell growth and death. (2006) (28)
Tissue distribution of restricted leukocyte common antigens. A comprehensive study with protein- and carbohydrate-specific CD45R antibodies. (1991) (28)
Sjögren's syndrome with specific cutaneous manifestations and multifocal clonal T-cell populations progressing to a cutaneous pleomorphic T-cell lymphoma. (1989) (28)
Expression of class II MHC antigens on alveolar epithelium in fibrosing alveolitis. (1987) (27)
Significance of c‐erb5‐2 amplification and DNA aneuploidy. Analysis in 78 patients with node‐negative breast cancer (1992) (27)
The typical Reed-Sternberg phenotype and Ig gene rearrangement of Hodgkin's disease derived cell line ZO indicating a B-cell origin. (1989) (27)
GA101, a novel humanized type IICD20Antibody with glycoengineered Fc and enhanced cell death induction, exhibits superior anti-tumor efficacy and superior tissue B cell depletion in vivo (2007) (27)
Cellular Localization and Processing of Primary Transcripts of Exonic MicroRNAs (2013) (26)
Frequent presence of subtype A virus in Epstein‐Barr virus‐associated malignancies (2002) (26)
Evidence for a migratory capability of rat Kupffer cells to portal tracts and hepatic lymph nodes (1986) (26)
Report: workshop on mediastinal grey zone lymphoma (2005) (25)
High expression of Mcl-1 in ALK positive and negative anaplastic large cell lymphoma (2005) (25)
INHIBITION OF ALLOREACTIVITY IN VITRO BY MONOCLONAL ANTIBODIES DIRECTED AGAINST RESTRICTED ISOFORMS OF THE LEUKOCYTE‐COMMON ANTIGEN (CD45) (1992) (25)
Biology of Hodgkin's disease. (1992) (25)
Tissue distribution of the C3d/EBV-receptor: CD21 monoclonal antibodies reactive with a variety of epithelial cells, medullary thymocytes, and peripheral T-cells (2004) (25)
Large-cell anaplastic lymphoma-specific translocation in Hodgkin's disease. (1995) (25)
Nodular lymphocyte predominance type of Hodgkin's disease is a B cell lymphoma. (1985) (24)
Hepatocellular Carcinomas in Cirrhotic and Noncirrhotic Human Livers Share Angiogenic Characteristics (2010) (24)
Epstein‐barr virus positivity in hodgkin's disease does not correlate with an hla a2‐negative phenotype (1994) (24)
bcl-1 gene rearrangements in mantle cell lymphoma: a comprehensive analysis of 118 cases, including B-5-fixed tissue, by polymerase chain reaction and Southern transfer analysis. (1998) (24)
Prognostic factors and changing trends in the treatment of Stage I endometrial cancer: a clinical and histopathological study of 182 patients. (1984) (24)
Prognostic significance of K-ras andTP53 mutations in the role of adjuvant chemotherapy on survival in patients with dukes C colon cancer (2001) (24)
Prognostic biomarkers in malignant lymphomas (2010) (24)
Dynamics of the vascular profile of the finer branches of the biliary tree in normal and diseased human livers. (2006) (23)
Anti‐CD45RB Monoclonal Antibody Prolongs Renal Allograft Survival in Cynomolgus Monkeys (2007) (23)
Diagnostic application of a monoclonal antibody against small cell lung cancer (1986) (23)
Alkaline phosphatase positive lymphomas: A morphologic, immunologic, and enzymehistochemical study (1981) (23)
Expression of CD1d and presence of invariant NKT cells in classical Hodgkin lymphoma† (2010) (22)
Cyclosporine inhibits long-term survival in cardiac allografts treated with monoclonal antibody against CD45RB. (1999) (22)
Immunophenotype of Reed-Sternberg cells. (1992) (22)
Array comparative genomic hybridization reveals a very high frequency of deletions of the long arm of chromosome 6 in testicular lymphoma (2006) (22)
Neoplastic Changes Involving Follicles: Morphological, Immunophenotypic and Genetic Diversity of Lymphoproliferations Derived from Germinal Center and Mantle Zone (1992) (21)
Early induction of MHC antigens in human liver grafts. An immunohistologic study. (1988) (21)
Spontaneous regression of a small non‐cleaved cell malignant lymphoma (Non‐burkitt's lymphoblastic lymphoma). Morphologic, immunohistological, and immunoglobulin gene analysis (1988) (21)
Hodgkin’s lymphoma associated T-cells exhibit a transcription factor profile consistent with distinct lymphoid compartments (2006) (20)
Expression of HLA Class I and HLA Class II by Tumor Cells in Chinese Classical Hodgkin Lymphoma Patients (2010) (20)
Impaired regeneration of biliary cells in human chronic liver allograft rejection. Special emphasis on the role of the finest branches of the biliary tree (2004) (20)
Small lymphocytic lymphomas with predominant splenomegaly: a comparison of immunophenotypes with cases of predominant lymphadenopathy. (1991) (20)
ATR alterations in Hodgkin's lymphoma. (2008) (19)
Localization of a fatty acid binding protein and its transcript in the developing chick retina. (1995) (19)
High expression of TIAF-1 in chronic kidney and liver allograft rejection and in activated T-helper cells1 (2002) (19)
Restricted V gene usage in T-cell lymphomas as detected by anti-T-cell receptor variable region reagents. (1991) (19)
Induction of B‐cell chronic lymphocytic leukaemia and hairy cell leukaemia like phenotypes by phorbol ester treatment of normal peripheral blood B‐cells (1990) (19)
In Situ Study of Haemopoiesis in Human Fetal Liver (1989) (19)
DNA analysis (ploidy) of molar pregnancies with image analysis on paraffin tissue sections. (1993) (19)
Mechanisms of induction of renal allograft tolerance in CD45RB-treated mice. (1999) (18)
Clinical drug‐resistant nodular sclerosing Hodgkin's lymphoma is associated with decreased bcl‐2 expression in the surrounding lymphocytes and with increased bcl‐2 expression in the Reed–Sternberg cells (2000) (18)
Lymphocyte function-associated antigen 1 (LFA-1) is a marker of mature (immunocompetent) lymphoid cells. A survey of lymphoproliferative diseases in man. (1985) (17)
Large-cell anaplastic lymphoma-specific translocation in Hodgkin's disease (1995) (17)
CLINICAL SIGNIFICANCE OF BCL2- MBR GENE REARRANGEMENT AND PROTEIN EXPRESSION IN DLBCL: AN ANALYSIS OF 83 CASES (1994) (17)
Lymphomatoid papulosis. Case report providing evidence for a monocyte–macrophage origin of the atypical cells (1983) (16)
OMENN SYNDROME - FAMILIAL RETICULO-ENDOTHELIOSIS WITH EOSINOPHILIA AND COMBINED IMMUNODEFICIENCY (1983) (16)
Extracellular ligation-dependent CD45RB enzymatic activity negatively regulates lipid raft signal transduction. (2009) (16)
Molecular characterization of the vascular features of focal nodular hyperplasia and hepatocellular adenoma: A role for angiopoietin‐1 (2010) (16)
HLA-A*02 is associated with a reduced risk and HLA-A*01 with an increased risk of developing EBV-positive Hodgkin lymphoma (2007) (15)
FAS gene mutation in a case of autoimmune lymphoproliferative syndrome type IA with accumulation of gammadelta+ T cells. (2003) (14)
Progressive renal failure due to renal invasion and parenchymal destruction by adult T-cell lymphoma. (1990) (14)
T‐lymphoblastic and peripheral T‐cell lymphomas in the northern part of the Netherlands. An immunologic study of 29 cases (1989) (14)
Prolonged survival of rat islet xenografts in mice after CD45RB monotherapy (2004) (14)
Antibody MT3 is reactive with a novel exon B-associated 190-kDa sialic acid-dependent epitope of the leukocyte common antigen complex. (1991) (13)
Impaired immune response to polysaccharides. (1987) (13)
Chronic lymphocytic leukemia with CNS involvement (1993) (13)
Postnatal changes of CD45 expression in peripheral blood T and B cells (1994) (13)
The heterogeneity of follicular center cell lymphomas. I. Cytohistologic, immunologic, and enzymehistochemical aspects (1983) (12)
Preservation of Bile Ductules Mitigates Bile Duct Loss (2006) (12)
The finest branches of the biliary tree might induce biliary vascularization necessary for biliary regeneration. (2006) (12)
BIOLOGY OF HODGKINS-DISEASE (1992) (12)
Significance of c-erbB-2 amplification and DNA aneuploidy. Analysis in 78 patients with node-negative breast cancer. (1992) (12)
35th Annual meeting of the European Association for the Study of Diabetes. Brussels, Belgium, 28 September-2 October, 1999. Abstracts. (1999) (11)
Localization of cytosolic aldehyde dehydrogenase in the developing chick retina: in situ hybridization and immunohistochemical analyses. (1996) (11)
Serial analysis of gene expression on primary Hodgkin and Reed-Sternberg cells (2007) (11)
Spectrum of malignant lymphomas in Klang Hospital, a public hospital in Malaysia. (2000) (10)
Frequent lack of translation of antigen presentation–associated molecules MHC class I, CD1a and B2‐microglobulin in Reed‐Sternberg cells (2000) (9)
TIMP‐1 expression in anaplastic large cell lymphoma is usually restricted to macrophages and only seldom observed in tumour cells (2005) (9)
Sternberg-Reed cells with intracytoplasmic lymphocytes (1978) (8)
A monoclonal antibody, 3G12, reacts with a novel surface molecule, Hal‐1, with high expression in CD30‐positive anaplastic large cell lymphomas (1999) (8)
Epstein-Barr Virus (EBV) Subtypes and Variants in Malignant Tissue from Malaysian Patients (2003) (8)
Lymphoma classification proposal. (1996) (8)
Simultaneous standard light microscopy and immunohistology on bronchoscopically procured lung cancer specimens. (1988) (8)
Vincristine‐induced apoptosis in vivo in peripheral blood mononuclear cells of children with acute lymphoblastic leukaemia (ALL) (2000) (8)
Automated procedure for dewaxing and rehydration of paraffin-embedded tissue sections for DNA flow cytometric analysis of breast tumors. (1991) (7)
DNA double-strand break rejoining in human follicular lymphoma and glioblastoma tumor cells. (2000) (7)
Acute rejection in human liver grafts: a comparative histologic study of cases maintained on azathioprine and prednisone versus cyclosporine A and low-dose steroids. (1988) (7)
T-cell subsets in liver diseases. (1984) (6)
Therapy for mouse renal allograft rejection by monoclonal antibody to CD45RB. (1996) (6)
Serum chemokine levels in Hodgkin lymphoma patients: Highly increased levels of thymus and activation-regulated chemokine and macrophage derived chemokine (2007) (6)
Morphometrical analysis of T- and B-cell compartments of spleens in Hodgkin’s disease (1981) (6)
The heterogeneity of follicular follicle center cell tumors. II. Clinical follow‐up of 30 patients (1983) (6)
The immunophenotypic patterns of follicle centre and mantle zone in Castleman's disease. (2003) (6)
Dual variant of Epstein‐Barr virus in Hodgkin/Reed‐Sternberg cells: Single‐cell PCR study on latent membrane protein‐1 gene (2003) (5)
Alkaline phosphatase positive lymphomas and lymphocytes. (1979) (5)
Cd4(+)Cd26(-) T cell population in classical Hodgkin lymphoma displays a distinctive regulatory T cell population (2007) (5)
The Nature of the Lymphocytes in Hodgkin’s Disease (1995) (5)
Regulatory T cells in Hodgkin lymphoma (2004) (5)
Patterns of leucocyte common antigen expression in peripheral blood T cell populations. (1993) (5)
Monoclonal Antibodies in Lymphoma Diagnosis and Classification. (1987) (5)
Follicular lymphoma grade 3B includes three cytogenetically defined subgroups with primary t(14;18), 3q27 or other translocations (2003) (5)
Reactivity of monoclonal antibody B-ly7 with a subset of activated T cells and T-cell lymphomas. (1992) (5)
CHROMOSOMAL-ABNORMALITIES IN HODGKINS-DISEASE (1992) (5)
Multiple HLA class I and II associations in classical Hodgkin lymphoma and EBV status defined subgroups. (2011) (5)
Effects of monoclonal antibody against CD45RB on peripheral blood mononuclear cell proliferation and on HLA-DR and adhesion molecule expression on thyrocytes of patients with autoimmune thyroid disease. (1995) (4)
Lymphoma: an introduction into historical background, classification schemes, aetiology, geographical variation and epidemiological trend. (2001) (4)
Immunogenicity and safety of SARS-CoV-2 vaccines in clinical trials. (2021) (4)
GA101: A humanized third generation type II CD20 antibody with superior cell death induction and glycoengineered Fc region for enhanced ADCC (2007) (4)
Binding of cardiolipin to polystyrene beads: evidence for a lamellar phase orientation (1995) (4)
Imbalances of T-cells in thymoma-associated hypogammaglobulinaemia. (1986) (4)
CD45 isoforms and lymphocyte activation antigens in acute renal allograft rejection. (1996) (4)
Evidence for a B-cell origin of the proliferating cells. (1989) (4)
Ischaemic colitis and lung infiltrates caused by extramedullary haematopoiesis in a patient with an acute erythroid leukaemia following polycythaemia vera. (1998) (4)
ANALYSIS OF MONONUCLEAR CELL INFILTRATES IN HUMAN-MALIGNANT MELANOMA - AN IMMUNOHISTOLOGICAL STUDY (1982) (4)
Novel third generation humanized type IICD20 antibody with superior direct cell death induction and glycoengineered Fc region for enhanced ADCC induction (2007) (4)
LYMPHOCYTE SUB-POPULATIONS AND IMMUNOGLOBULINS IN LIVER-BIOPSY SPECIMENS WITH PIECEMEAL NECROSIS (1981) (3)
In Situ Analysis of Mononuclear Cell Infiltrate in Liver Biopsies of Patients with Orthotopic Liver Transplantation (1983) (3)
Microenvironment, Cross-Talk, and Immune Escape Mechanisms (2015) (3)
The micro-RNA expression profile in Hodgkin lymphoma (2007) (3)
Differential effects of CD45 reagents on T cell activation. (1996) (3)
Lymphocyte predominant Hodgkin lymphoma, antigen‐driven after all? (2020) (3)
Critical Evaluation of New Techniques in the Morphological Diagnosis of Lung Cancer (1986) (3)
IG GENE REARRANGEMENT IN HODGKINS-DISEASE CELL-LINE (1985) (3)
Characterization of monoclonal antibodies to epithelial antigens expressed on breast cancer cells and absent on hematopoietic cells (1995) (3)
Non-Hodgkin’s lymphoma with multilobated nuclei is not a distinct pathologic entity (1985) (3)
MONOCLONAL-ANTIBODY REACTIVE WITH HAIRY-CELL LEUKEMIA AND A MINOR NORMAL LYMPHOCYTE SUBPOPULATION (1986) (3)
Nodular Lymphocyte-Predominant Type of Hodgkin's Lymphoma (2011) (3)
TARC and MDC are the only chemokines with highly increased levels in serum of Hodgkin lymphoma patients (2006) (3)
LEFT PARAVERTEBRAL MASS (1987) (3)
Angiogenic characteristics in hepatocellular carcinomas. A comparison of HCCS in cirrhotic and non-cirrhotic livers and the influence of grading (2006) (3)
DNA measurements in thin sections of lymphomas. (1985) (3)
Characterization of the alkaline phosphatase expressed on the surface of a Hodgkin's lymphoma cell line. (1993) (2)
The diagnostic use of monoclonal antibodies against small cell lung carcinoma cells. (1985) (2)
Prevention, Reversal of Rejection and Induction of Tolerance by Monoclonal Antibody to CD45 RB in Monkey Kidney Transplant Model - A Preliminary Report (1998) (2)
MIGRATION OF KUPFFER CELLS IN THE RAT (1986) (2)
Genetics, biology and classification of non-Hodgkin's lymphomas (NHL) (2003) (2)
Polymorphisms and lack of or aberrant expression of HLA class I and II may influence antigen presentation in classical Hodgkin lymphoma. (2005) (2)
KI-1 (CD30) ANTIGEN EXPRESSION ON TRANSFORMED FOLLICULAR LYMPHOMAS (1990) (2)
BIC and miR-155 are highly expressed in Hodgkin, priniary mediastinal and diffuse large B cell lymphomas (2005) (2)
LIVER MEMBRANE AUTOANTIBODIES AND THE PATHOGENESIS OF LIVER-DISEASE (1985) (2)
Some CD26 reagents directly activate T cells. (1996) (2)
Double immunoenzymatic staining employing rat and mouse monoclonal antibodies. (1985) (2)
Immunogold labelling of leukemic hairy cells with the B‐ly7 monoclonal antibody: An SEM and TEM study (1994) (2)
Regional Diets Targeting Gut Microbial Dynamics to Support Prolonged Healthspan (2021) (2)
Unexpected Specificities of Monoclonal Antibodies (1983) (2)
Absence of estrogen receptors in a case of virginal hypertrophy of the breasts related to oral contraceptives (1993) (2)
Short Communication Low Frequency of FAS Mutations in Reed-Sternberg Cells of Hodgkin's Lymphoma (2003) (2)
Intermediate filament expression in small cell lung cancer; poor correlation to in vitro data. (1987) (2)
Monocytoid B cells are bcl-2 protein negative similar to germinal center cells and in contrast to marginal zone cells and monocytoid B cell lymphoma (1995) (2)
HLA-G expression in classical Hodgkin lymphoma. (2003) (1)
FAS Gene Mutation in a Case of Autoimmune Lymphoproliferative Syndrome Type IA With Accumulation of + T Cells (2003) (1)
The angiogenic make up of human hepatocellular carcinoma does not favour VEGF/angiopoietin driven sprouting neovascularization (2007) (1)
Lymphocyte subpopulations in peripheral blood and bone marrow in patients with idiopathic myelofibrosis (1987) (1)
428 Preservation of canals of hering mitigates bile duct loss in liver graft rejection (2003) (1)
Latent EBV infection of Hodgkin Reed-Sternberg cells predicts adverse outcome in older adult classical Hodgkin lymphoma patients (2007) (1)
CD45(R) reagents can modulate the T cell response in vitro and in vivo. (1996) (1)
Immunophenotype and functional characteristics of T cells in Hodgkin's disease (1995) (1)
A High Throughput Experimental Approach to Identify miRNA Target Genes in Hodgkin Lymphoma (2008) (1)
MIGRATION OF KUPFFER CELLS FROM RAT-LIVER TO REGIONAL LYMPH-NODES (1984) (1)
High expression of micro-RNA BIC/miR155 in all subtypes of Hodgkin lymphoma (2004) (1)
miRNA Profiling of B Cell Subsets: Specific miRNA Profile for Germinal Center B Cells with a Marked Variation Between Centroblast and Centrocytes. (2008) (1)
ALKALINE-PHOSPHATASE POSITIVE LYMPHOMA, FUNCTIONAL AND MORPHOLOGICAL ASPECTS (1978) (1)
5′-UTR FAS mutation pattern and frequency in nodal diffuse large B-cell lymphoma similar to normal germinal center B cells (2007) (1)
DETECTION OF SURFACE-IMMUNOGLOBULIN IN MALIGNANT-LYMPHOMAS WITH THE IMMUNOPEROXIDASE TECHNIQUE (1981) (1)
ARE LIVER MEMBRANE ANTIBODIES IMPORTANT IN THE PATHOGENESIS OF CHRONIC ACTIVE LIVER-DISEASE (1982) (1)
Immunopathology. : Handbook of experimental immunology. (1997) (1)
miRNA Profiling of B Cell Subsets (2008) (1)
The absence of effective T-cell activation in Hodgkin's disease may be the result of TGF beta production by Reed-Sternberg cells. (1997) (1)
Early Induction ofMHC Antigens in Human Liver Grafts (2007) (1)
Chapter 5 Gene expression study in dendritic / Langerhans cells and Langerhans cell histiocytosis cases (2006) (1)
Vascular profile of the canals of Hering in normal and diseased human livers. (2001) (1)
IMMUNE-REACTIONS AND VIRAL-ANTIGENS IN LIVER-BIOPSY SPECIMENS FROM PATIENTS WITH ACUTE AND CHRONIC HEPATITIS-B (1983) (1)
Study of haemopoiesis in the human embryonal and foetal liver. (1987) (1)
DNA CYTOMETRY - DIPLOID STANDARD AND SECTION THICKNESS - REPLY (1994) (1)
Identification of chromosomal copy number changes associated with transformation of follicular to diffuse large cell lymphoma. (2002) (1)
In vitro system for evaluation of the immunomodulatory capacity of CD45(R) reagents. (1996) (1)
Identification of the human Bic gene in Hodgkin's lymphoma. (2000) (1)
Canals of hering and the development of ductopenia in chronic liver allograft rejection. (2001) (0)
University of Groningen Expression of HLA Class I and HLA Class II by Tumor Cells in Chinese Classical Hodgkin Lymphoma Patients (2019) (0)
Chapter 2 High expression of calcium binding proteins , S 100 A 10 , S 100 A 11 and CALM 2 in anaplastic large cell lymphoma (2006) (0)
Infantile histiocytosis X. (1978) (0)
IMMUNOLOGY 2004: GENOMIC ISSUES, IMMUNE SYSTEM ACTIVATION AND ALLERGY (2004) (0)
No increase of apoptosis can be observed in bone marrow histology by TUNEL and electron microscopy in myelodysplasia patients (1998) (0)
THE SIGNIFICANCE OF PARENCHYMAL CHANGES OF ACUTE REJECTION IN PREDICTING CHRONIC LIVER GRAFT REJECTION.: Abstract# 32 (2000) (0)
Dukes'C colon cancer after adjuvant treatment: can KRAS and PT 53 mutations serve as prognostic indicators? (1999) (0)
Haplotype-based sequencing to delineate the associated HLA class I region for EBV positive Hodgkin lymphoma (2005) (0)
Association of HLA type with Epstein Barr positivity and HLA class I loss in classical Hodgkin lymphoma patients from Northern China (2010) (0)
Genetic fine-mapping and characterization of mutations of genes in the HLA region that predispose or protect for the development of EBV-positive and -negative subtypes of classical Hodgkin's lymphomas (2000) (0)
TheNature oftheLymphocytes Surrounding Reed-Sternberg Cells inNodular Lymphocyte Predominance andinOther Types ofHodgkin's Disease (1989) (0)
Mass Spectrometry-Based Glycoproteomic Profiling Identifies Distinct Protein Biomarkers of Hodgkin Lymphoma (2011) (0)
nodes and spleens involved by Hodgkin's disease In situ immunologic characterization of cellular constituents in lymph (2011) (0)
ANGIOGENESIS IN BENIGN HUMAN HEPATIC TUMORS A ROLE FOR ANG-1/TIE-2? (2009) (0)
Tumor cell survival strategies in Hodgkin lymphoma (2010) (0)
Differential expression of CD80 (B7-1) and CD86 (B7-2) surface molecules by Hodgkin and Reed-Sternberg cells : Functional involvement in the cellular interaction characteristically seen in Hodgkin's disease (1996) (0)
[Lymphomatoid papulosis]. (1983) (0)
Expression of ICOS and ICOS-L in distinct subtypes of Hodgkin lymphoma (2003) (0)
Regulation of pri-miRNA BIC transcription and processing in burkitt lymphoma. (2006) (0)
PREVALENCE OF EPSTEIN-BARR-VIRUS IN MIXED CELLULARITY HODGKINS-DISEASE (1993) (0)
Using antibodies against CD45RO leukocyte antigen for immunomodulation (1997) (0)
Cytokine gene expression profile distinguishes CD4(+)/CD57' T-cells of nodular lymphocyte predominance type of Hodgkin lymphoma from their tonsillar counterparts (2005) (0)
Expression of CD1c, CD1d and Presence of Invariant NKT Cells in Hodgkin Lymphoma. (2009) (0)
T-CELL RECEPTOR VARIABLE REGION ANALYSIS IN KIKUCHIS DISEASE (1991) (0)
Identification of FAS gene mutation in a patient with nodular lymphocyte predominance Hodgkin's lymphoma and autoimmune lymphoproliferative syndrome. (2000) (0)
Absence of putative hepatic stem cells in end-stage chronic liver allograft rejection. (2000) (0)
Protective and Predisposing HLA Alleles In Dutch Classical Hodgkin Lymphoma Patients (2010) (0)
DIVERSITY OF LEUKOCYTE COMMON ANTIGEN (CD45) EXPRESSION (1994) (0)
regulates lipid raft signal transduction Extracellular ligation-dependent CD45RB enzymatic activity negatively (2013) (0)
Chapter 20 Neuroendocrine and epithelial differentiation antigen expression in newly diagnosed small cell lung cancer (1988) (0)
Corrigendum to "Hodgkin Lymphoma Cell Lines Are Characterized by a Specific miRNA Expression Profile." Neoplasia 2009, Feb;11(2):167-176. (2018) (0)
FAS Gene Mutation in a Case of Autoimmune Lymphoproliferative Syndrome Type IA With Accumulation of &ggr;&dgr;+ T Cells (2003) (0)
Cytokine gene expression and T-cell transcription factor profile of the T-cells of the nodular lymphocyte predominance type of Hodgkin's lymphoma (2007) (0)
Characteristics of T cells in Hodgkin's disease. (1996) (0)
CD45RB monoclonal antibody prolongs renal allograft survival in cynomolgus monkeys (2006) (0)
HLA ASSOCIATIONS IN CLASSICAL HODGKIN LYMPHOMA: AGE MATTERS (2013) (0)
Serial analysis of gene expression to identify functionally relevant gene expression in T-lymphocyte subsets. (2000) (0)
Short Communication Absence of HLA Class I Expression by Reed-Sternberg Cells (2007) (0)
One amino acid change in the peptide binding region of HLA-A*02 converts protection into an increased risk for EBV positive Chinese classical Hodgkin Lymphoma patients (2011) (0)
University of Groningen Expression of the c-Met oncogene by tumor cells predicts a favorable outcome in classical Hodgkin's lymphoma (2012) (0)
Expression of T-cell associated transcription factors in Hodgkin lymphoma tissues and cell lines. (2003) (0)
HLA Associations in EBV Status Defined Subgroups of Classical Hodgkin Lymphoma (2014) (0)
TP53 gene mutations in Hodgkin's lymphoma are infrequent and not related to Epstein-Barr virus status. (2000) (0)
Immunophenotyping of putative progenitor cells and bile ductular cells in normal and diseased human livers. (1999) (0)
PLOIDY OF LYMPHOMAS (1985) (0)
Nodular Lymphocyte Predominant Hodgkin Lymphoma : Evolution to a separate entity in the WHO classification (2004) (0)
Functional analysis of micro-RNA molecules that are specifically and highly expressed in Hodgkin lymphoma (2006) (0)
Specific micro-RNA expression profile in Hodgkin lymphoma (2007) (0)
Discovery of biomarkers for Hodgkin lymphoma using proteomics technology. (2006) (0)
Expression and Characterization of Leucocyte Antigens (1984) (0)
LYMPHOCYTIC LYMPHOMAS WITH SPLENOMEGALY HAVE A DISTINCT IMMUNOPHENOTYPE, DIFFERENT FROM THAT OF CASES WITH LYMPHADENOPATHY (1991) (0)
DIVERSITY OF EXPRESSION OF THE LEUKOCYTE ANTIGEN FAMILY (1990) (0)
Platelet activation by immobilised von Willebrand factor-coated beads: Evidence for a novel adhesion mechanism involving alpha v beta 3, and GPIIb/IIIa (1995) (0)
The essential role of the thymus in the differentiation and functional maturation of bone marrow-derived precursors into immunocompetent T lymphocytes is well estab- (2003) (0)
Identification of McI-1 expression in ALK plus anaplastic large cell lymphoma by cDNA arrays (2001) (0)
The role of the university in recovering from COVID-19 and preparing for future crises—perspectives and experiences from Sunway University, Malaysia (2023) (0)
Serial analysis of gene expression revealed consistent downregulation of more than 100 genes in Hodgkin lymphoma. (2004) (0)
Evaluation of 110 cases of mantle cell lymphoma by PCR and southern transfer for the detection of immunoglobulin heavy chain, and bcl-1 locus rearrangements in frozen, formalin and B-5 fixed tissue. (1996) (0)
Loss of putative hepatic stem cells in chronic liver allograft rejection. (2000) (0)
Serial analysis of gene expression (1999) (0)
MONOCYTOID B-CELL LYMPHOMA - A CLINICOPATHOLOGICAL STUDY OF 35 CASES (1992) (0)
CUTANEOUS MALIGNANT EPIDERMOTROPIC LYMPHOMA, POSSIBLY OF MONOCYTIC ORIGIN (1983) (0)
CLONALITY OF T-CELL LYMPHOMAS AS DETECTED BY ANTI T-CELL RECEPTOR VARIABLE REGION REAGENTS (1991) (0)
Population based genotyping of human leukocyte antigen (HLA) in Hodgkin lymphoma (2004) (0)
Re: Rust et al. TIMP-I expression in anaplastic large cell lymphoma is usually restricted to macrophages and only seldom observed in tumour cells. J Pathol 2005; 206 : 445-450 - Reply (2005) (0)
Lymphocyte-predominance Hodgkin's disease. (1992) (0)
No vessels, no ductules? The role of intact vascularization in regeneration of the biliary tree. (2004) (0)
Left paravertebral mass: giant lymph node hyperplasia. (1987) (0)
Contribution of Deregulated miRNAs to the Phenotypic Characteristic of Hodgkin Lymphoma (2009) (0)
Autoimmune lymphoproliferative syndrome type Ia with accumulation of gamma delta T cells. (2001) (0)
Quantitation of infiltrating T lymphocytes in grade I acute rejection one week after OLT: Is it helpful in determining the need for anti-rejection therapy? (1996) (0)
IDENTIFICATION OF HODGKIN LYMPHOMA BIOMARKERS USING GLYCOPROTEOMIC PROFILING (2011) (0)
Authors' reply (2005) (0)
The HGF/c-Met signaling pathway in Hodgkin lymphoma (2010) (0)
Hodgkin's disease Clonal immunoglobulin gene rearrangements in tissues involved by (2011) (0)
Angiogenesis in benign hepatic tumors: a role for Angiopoietin-1/Tie-2? (2009) (0)
HLA Class I and EBV Positive Classical Hodgkin Lymphoma In the Chinese Population. (2010) (0)
FOLLICULAR NON-HODGKIN LYMPHOMA - A CLINICAL NOR A HISTOLOGICAL ENTITY (1982) (0)
Expression of the c-Met Oncogene Correlates with Favorable Progression Free Survival In Classical Hodgkin Lymphoma (2010) (0)
defines an activation antigen on normal CD8+ T cells (see comments) B-ly-7, a monoclonal antibody reactive with hairy cell leukemia, also (2011) (0)
Lymphocyte-rich classical Hodgkin's disease (LRCHD) : Clinical relevance of a provisional entity (1997) (0)
Repression of Mir-106b Family Members Does Not Alter Cell Cycle Progression in Hodgkin Lymphoma (2008) (0)
CCR4 Expression in Hodgkin Lymphoma (2011) (0)
Active Specific Immunotherapy in the Management of Adenocarcinoma of the Pancreas (1995) (0)
Shedding of L-selectin as induced by anti-CD45RB does not involve TACE/ADAM17 (2004) (0)
SIALOSYL-TN (B72.3) SHOWS COORDINATED EXPRESSION WITH POLYMORPHIC EPITHELIAL MUCIN IN NORMAL AND MALIGNANT BREAST AFTER TRYPSIN PRETREATMENT (1995) (0)
CUTANEOUS IMMUNOBLASTIC T-CELL LYMPHOMA (1988) (0)
The HGF/c-Met Signaling Pathway in Hodgkin Lymphoma. (2009) (0)
Prolonged survival of rat-islet xenografts in mice by CD45RB antibody monotherapy. (1999) (0)
involved in the cross-talk between HRS cells and infiltrating lymphocytes Proteomics analysis of Hodgkin lymphoma: Identification of new players (2013) (0)
Dukes'C colon cancer after adjuvant treatment (1999) (0)
Deregulated immune response in Hodgkin's lymphomas (1998) (0)
ACTIVE SPECIFIC IMMUNOTHERAPY FOR PANCREATIC ADENOCARCINOMA (1994) (0)
roeotgenogram ofthemonth Left Paravertebral Mass (2015) (0)
Cytogenetic, histologic and immunophenotypic evidence for tumor progression in two lymph node biopsies obtained at the same time of a patient with follicular lymphoma. (1997) (0)
The pattern of TARC, a CC chemokine, in Malaysian lymphomas (2000) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Sibrandes Poppema?

Sibrandes Poppema is affiliated with the following schools:

Sibrandes Poppema's Academic­Influence.com Rankings